Last quarter (Q2 2023), Alibaba Health Information Technology's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Alibaba Health Information Technology's net income was $―. See Alibaba Health Information Technology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	$ ―	$ ―	$ 20.58B	$ 15.52B	$ 9.60B	$ 5.10B
Cost of Revenue	$ ―	$ ―	$ 16.47B	$ 11.90B	$ 7.37B	$ 3.76B
Gross Profit	$ ―	$ ―	$ 4.11B	$ 3.62B	$ 2.23B	$ 1.33B
Operating Expense	$ ―	$ ―	$ 5.13B	$ 3.51B	$ 2.27B	$ 1.42B
Operating Income	$ ―	$ ―	$ -1.02B	$ 110.83M	$ -42.15M	$ -93.33M
Net Non Operating Interest Income Expense	$ ―	$ ―	$ 206.02M	$ 162.97M	$ 34.25M	$ -2.91M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ ―	$ -252.51M	$ 401.22M	$ 9.09M	$ -60.83M
Tax Provision	$ ―	$ ―	$ 13.43M	$ 58.54M	$ 24.79M	$ 30.93M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ ―	$ -265.56M	$ 348.59M	$ -6.59M	$ -81.95M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ 21.60B	$ 15.41B	$ 9.64B	$ 5.19B
Net Income From Continuing And Discontinued Operation	$ ―	$ ―	$ -265.56M	$ 348.59M	$ -6.59M	$ -81.95M
Normalized Income	$ ―	$ ―	$ -591.71M	$ 231.04M	$ -54.27M	$ -104.52M
Interest Expense	$ ―	$ ―	$ 3.81M	$ 2.45M	$ 21.96M	$ 27.97M
EBIT	$ ―	$ ―	$ -248.70M	$ 403.67M	$ 31.06M	$ -32.86M
EBITDA	$ ―	$ 620.55M	$ -188.12M	$ 443.29M	$ 72.75M	$ -28.88M

Currency in USD

Alibaba Health Information Technology Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing